1,280
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Chemotherapy-induced microbiota exacerbates the toxicity of chemotherapy through the suppression of interleukin-10 from macrophages

, , , , , , , & show all
Article: 2319511 | Received 12 Oct 2023, Accepted 12 Feb 2024, Published online: 24 Feb 2024

References

  • Yoshino T, Arnold D, Taniguchi H, Pentheroudakis G, Yamazaki K, Xu RH, Kim TW, Ismail F, Tan IB, Yeh KH. et al. Pan-asian adapted esmo consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol. 2018;29(1):44–22. doi:10.1093/annonc/mdx738.
  • Abu-Sbeih H, Mallepally N, Goldstein R, Chen E, Tang T, Dike UK, Al-Asadi M, Westin S, Halperin D, Wang Y. Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy. J Cancer. 2020;11(11):3144–3150. doi:10.7150/jca.37777.
  • Kang L, Tian Y, Xu S, Chen H. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. J Neurol. 2021;268(9):3269–3282. doi:10.1007/s00415-020-09942-w.
  • Stack A, Khanal R, Denlinger CS. Oxaliplatin-induced immune thrombocytopenia: a case report and literature review. Clin Colorectal Cancer. 2021;20(1):e1–e4. doi:10.1016/j.clcc.2020.07.007.
  • Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut. 2020;69(10):1867–1876. doi:10.1136/gutjnl-2020-321153.
  • Guo H, Chou WC, Lai Y, Liang K, Tam JW, Brickey WJ, Chen L, Montgomery ND, Li X, Bohannon LM. et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science. 2020;370(6516). doi:10.1126/science.aay9097
  • Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, Dupont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC. et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med. 2018;24(12):1804–1808. doi:10.1038/s41591-018-0238-9.
  • De Pietri S, Ingham AC, Frandsen TL, Rathe M, Krych L, Castro-Mejía JL, Nielsen DS, Nersting J, Wehner PS, Schmiegelow K. et al. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota. Int J Cancer. 2020;147(7):1953–1962. doi:10.1002/ijc.32942.
  • Ding C, Tang W, Fan X, Wu G. Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. Onco Targets Ther. 2018;11:4797–4810. doi:10.2147/OTT.S170626.
  • Grant CV, Loman BR, Bailey MT, Pyter LM. Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice. Brain Behav Immun. 2021;95:401–412. doi:10.1016/j.bbi.2021.04.014.
  • Berthold DL, Jones K, Udalova IA. Regional specialization of macrophages along the gastrointestinal tract. Trends Immunol. 2021;42(9):795–806. doi:10.1016/j.it.2021.07.006.
  • Yang Y, Li L, Xu C, Wang Y, Wang Z, Chen M, Jiang Z, Pan J, Yang C, Li X. et al. Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis. Gut. 2020;70(8):1495–1506. doi:10.1136/gutjnl-2020-320777.
  • Li M, Chen J, Liu S, Sun X, Xu H, Gao Q, Chen X, Xi C, Huang D, Deng Y. et al. Spermine-related DNA hypermethylation and elevated expression of genes for collagen formation are susceptible factors for chemotherapy-induced hand-foot syndrome in Chinese colorectal cancer patients. Front Pharmacol. 2021;12:746910. doi:10.3389/fphar.2021.746910.
  • Chen LX, Qi YL, Qi Z, Gao K, Gong RZ, Shao ZJ, Liu SX, Li SS, Sun YS. A comparative study on the effects of different parts of panax ginseng on the immune activity of cyclophosphamide-induced immunosuppressed mice. Molecules. 2019;24(6):1096. doi:10.3390/molecules24061096.
  • Aston WJ, Hope DE, Nowak AK, Robinson BW, Lake RA, Lesterhuis WJ. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. BMC Cancer. 2017;17(1):684. doi:10.1186/s12885-017-3677-7.
  • Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, O’Neill LA, Xavier RJ. Trained immunity: a program of innate immune memory in health and disease. Science. 2016;352(6284):aaf1098. doi:10.1126/science.aaf1098.
  • Lee J, D’Aigle J, Atadja L, Quaicoe V, Honarpisheh P, Ganesh BP, Hassan A, Graf J, Petrosino J, Putluri N. et al. Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice. Circ Res. 2020;127(4):453–465. doi:10.1161/CIRCRESAHA.119.316448.
  • Jobin C. Gpr109a: the missing link between microbiome and good health? Immunity. 2014;40(1):8–10. doi:10.1016/j.immuni.2013.12.009.
  • Lin XB, Dieleman LA, Ketabi A, Bibova I, Sawyer MB, Xue H, Field CJ, Baracos VE, Gänzle MG, Ahmed N. Irinotecan (cpt-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PloS One. 2012;7(7):e39764. doi:10.1371/journal.pone.0039764.
  • Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330(6005):831–835. doi:10.1126/science.1191175.
  • Pollet RM, D’Agostino EH, Walton WG, Xu Y, Little MS, Biernat KA, Pellock SJ, Patterson LM, Creekmore BC, Isenberg HN. et al. An atlas of β-glucuronidases in the human intestinal microbiome. Structure. 2017;25(7):967–977. doi:10.1016/j.str.2017.05.003.
  • Rajagopala SV, Singh H, Yu Y, Zabokrtsky KB, Torralba MG, Moncera KJ, Frank B, Pieper R, Sender L, Nelson KE. Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (all) during chemotherapy. Microb Ecol. 2020;79(4):1034–1043. doi:10.1007/s00248-019-01448-x.
  • Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017;14(6):356–365. doi:10.1038/nrgastro.2017.20.
  • Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971–976. doi:10.1126/science.1240537.
  • Dubin K, Callahan MK, Ren B, Khanin R, Viale A, Ling L, No D, Gobourne A, Littmann E, Huttenhower C. et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun. 2016;7(1):10391. doi:10.1038/ncomms10391.
  • Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP. et al. Anticancer immunotherapy by ctla-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079–1084. doi:10.1126/science.aad1329.
  • Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML. et al. Commensal bifidobacterium promotes antitumor immunity and facilitates anti-pd-l1 efficacy. Science. 2015;350(6264):1084–1089. doi:10.1126/science.aac4255.
  • Ouyang W, O’Garra A. Il-10 family cytokines il-10 and il-22: from basic science to clinical translation. Immunity. 2019;50(4):871–891. doi:10.1016/j.immuni.2019.03.020.
  • Saraiva M, O’Garra A. The regulation of il-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170–181. doi:10.1038/nri2711.
  • Hayashi A, Sato T, Kamada N, Mikami Y, Matsuoka K, Hisamatsu T, Hibi T, Roers A, Yagita H, Ohteki T. et al. A single strain of clostridium butyricum induces intestinal il-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe. 2013;13(6):711–722. doi:10.1016/j.chom.2013.05.013.
  • Naing A, Wong DJ, Infante JR, Korn WM, Aljumaily R, Papadopoulos KP, Autio KA, Pant S, Bauer TM, Drakaki A. et al. Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (ivy): a multicentre, multicohort, open-label, phase 1b trial. Lancet Oncol. 2019;20(11):1544–1555. doi:10.1016/S1470-2045(19)30514-5.
  • Costes L, Lindenbergh-Kortleve DJ, van Berkel LA, Veenbergen S, Raatgeep H, Simons-Oosterhuis Y, van Haaften DH, Karrich JJ, Escher JC, Groeneweg M. et al. Il-10 signaling prevents gluten-dependent intraepithelial cd4(+) cytotoxic t lymphocyte infiltration and epithelial damage in the small intestine. Mucosal Immunology. 2019;12(2):479–490. doi:10.1038/s41385-018-0118-0.
  • Gunasekera DC, Ma J, Vacharathit V, Shah P, Ramakrishnan A, Uprety P, Shen Z, Sheh A, Brayton CF, Whary MT. et al. The development of colitis in il10(-/-) mice is dependent on il-22. Mucosal Immunol. 2020;13(3):493–506. doi:10.1038/s41385-019-0252-3.
  • Zaimoku Y, Patel BA, Kajigaya S, Feng X, Alemu L, Quinones RD, Groarke EM, Young NS. Deficit of circulating cd19(+) cd24(hi) cd38(hi) regulatory b cells in severe aplastic anaemia. Br J Haematol. 2020;190(4):610–617. doi:10.1111/bjh.16651.
  • Feng X, Lin Z, Sun W, Hollinger MK, Desierto MJ, Keyvanfar K, Malide D, Muranski P, Chen J, Young NS. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure. Haematologica. 2017;102(10):1691–1703. doi:10.3324/haematol.2017.163675.
  • Wei HJ, Gupta A, Kao WM, Almudallal O, Letterio JJ, Pareek TK. Nrf2-mediated metabolic reprogramming of tolerogenic dendritic cells is protective against aplastic anemia. J Autoimmun. 2018;94:33–44. doi:10.1016/j.jaut.2018.07.005.
  • Agnes JP, Santos V, Das NR, Gonçalves RM, Delgobo M, Girardi CS, Lückemeyer DD, Ferreira MA, Macedo-Júnior SJ, Lopes SC. et al. Antioxidants improve oxaliplatin-induced peripheral neuropathy in tumor-bearing mice model: role of spinal cord oxidative stress and inflammation. The Journal Of Pain. 2021;22(8):996–1013. doi:10.1016/j.jpain.2021.03.142.
  • Wong D, Holanda R, Cajado AG, Bandeira AM, Pereira J, Amorim JO, Torres CS, Ferreira L, Lopes M, Oliveira R. et al. Tlr4 deficiency upregulates tlr9 expression and enhances irinotecan-related intestinal mucositis and late-onset diarrhoea. Br J Pharmacol. 2021;178(20):4193–4209. doi:10.1111/bph.15609.
  • Karlsson M, Scherbak N, Reid G, Jass J. Lactobacillus rhamnosus gr-1 enhances nf-kappab activation in Escherichia coli-stimulated urinary bladder cells through tlr4. BMC Microbiol. 2012;12(1):15. doi:10.1186/1471-2180-12-15.
  • Zabłocka A, Jakubczyk D, Leszczyńska K, Pacyga-Prus K, Macała J, Górska S. Studies of the impact of the bifidobacterium species on inducible nitric oxide synthase expression and nitric oxide production in murine macrophages of the bmdm cell line. Probiotics Antimicrob Proteins. 2023;10.1007/s12602–023–10093–3. doi:10.1007/s12602-023-10093-3.
  • Ma T, Shen X, Shi X, Sakandar HA, Quan K, Li Y, Jin H, Kwok L, Zhang H, Sun Z. Targeting gut microbiota and metabolism as the major probiotic mechanism - an evidence-based review. Trends Food Sci Technol. 2023;138:178–198. doi:10.1016/j.tifs.2023.06.013.
  • Mcdonald D, Jiang Y, Balaban M, Cantrell K, Zhu Q, Gonzalez A, Morton JT, Nicolaou G, Parks DH, Karst SM. et al. Author correction: Greengenes2 unifies microbial data in a single reference tree. Nat Biotechnol. 2023:10.1038/s41587–023–01845–1. doi:10.1038/s41587-023-02026-w
  • He Z, Wu J, Gong J, Ke J, Ding T, Zhao W, Cheng WM, Luo Z, He Q, Zeng W. et al. Microbiota in mesenteric adipose tissue from crohn’s disease promote colitis in mice. Microbiome. 2021;9(1):228. doi:10.1186/s40168-021-01178-8.